Skip to content

Documentation of Heart Failure in a Gulf Registry

Gulf Documentation of Ambulatory Sick Patients With Heart Failure Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02793180
Acronym
DYSPNEA
Enrollment
3680
Registered
2016-06-08
Start date
2016-11-07
Completion date
2018-02-19
Last updated
2018-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

In the Middle East and the Gulf, the general population have high cardiovascular risks like diabetes, hypertension, smoking and obesity. The average age of a patient with an acute coronary syndrome (ACS) event is relatively young compared to Western populations. Women are multiparous and the rates of consanguinity marriages are high in this region of the world. These risk factors and conditions result in heart failure. Great deal of knowledge is missing regarding the influence of these risk factors on heart failure presentation, the causes and management of heart failure in ambulatory patients in this region of the world.

Interventions

None listed

Sponsors

Gulf Heart Association
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Is over the age of 21. 2. Has been diagnosed with heart failure, regardless of cause. 3. Is presenting to the outpatient clinic of an internist or cardiologist for follow up. 4. Provides a written consent.

Exclusion criteria

1. Prior enrolment in this study. 2. Refusal or inability to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Quantifying the causes of heart failure in the ambulatory patients in the outpatient settingSingle time point at baseline upon inclusion (cross-sectional)Number of participants with main reason due to heart failure from Coronary Artery Disease (CAD), Hypertension, Valvular, Idiopathic Dilated Cardiomyopathy, Congenital, Pregnancy / delivery related, or other reason to be specified

Secondary

MeasureTime frameDescription
Measure investigations that heart failure patients undergoUp to 6 months before inclusionNumber of participants who have had echocardiography done less than 1 month, 1-6 months, greater than 6 months from enrollment
Measuring patient functional status in heart failure patientsSingle time point at baseline upon inclusion (cross-sectional)* Number of participants who can walk independently, walk with assistance, or are unable to walk. * Number of participants who are limited in dressing, somewhat limited, or not limited. * Number of participants who are can shower in a limited manner, somewhat limited, or not limited
Relationship between cardiovascular risk factors and heart failureSingle time point at baseline upon inclusion (cross-sectional)
Measuring Management Gaps in heart failure patientsPast 12 months upon inclusion* Number of participants with 0, 1, 2, or greater than 2 emergency room visits related to heart failure * Number of participants with 0,1, 2, or greater than 2 hospital admissions related to heart failure

Other

MeasureTime frameDescription
Quantifying the distribution of heart failure typesSingle time point at baseline upon inclusion (cross-sectional)Number of participants that will either have preserved or reduced left ventricular systolic function

Countries

Kuwait

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026